IL104357A0 - Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester,its preparation and pharmaceutical compositions containing it - Google Patents

Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester,its preparation and pharmaceutical compositions containing it

Info

Publication number
IL104357A0
IL104357A0 IL104357A IL10435793A IL104357A0 IL 104357 A0 IL104357 A0 IL 104357A0 IL 104357 A IL104357 A IL 104357A IL 10435793 A IL10435793 A IL 10435793A IL 104357 A0 IL104357 A0 IL 104357A0
Authority
IL
Israel
Prior art keywords
dihydropyridine
preparation
specific
acid ester
pharmaceutical compositions
Prior art date
Application number
IL104357A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL104357A0 publication Critical patent/IL104357A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
IL104357A 1992-01-14 1993-01-11 Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester,its preparation and pharmaceutical compositions containing it IL104357A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4200714A DE4200714A1 (de) 1992-01-14 1992-01-14 Spezieller 1,4-dihydropyridin-3,5-dicarbonsaeureester, verfahren zu seiner herstellung und seine pharmazeutische verwendung

Publications (1)

Publication Number Publication Date
IL104357A0 true IL104357A0 (en) 1993-05-13

Family

ID=6449473

Family Applications (1)

Application Number Title Priority Date Filing Date
IL104357A IL104357A0 (en) 1992-01-14 1993-01-11 Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester,its preparation and pharmaceutical compositions containing it

Country Status (14)

Country Link
US (1) US5342847A (xx)
EP (1) EP0551663A1 (xx)
JP (1) JPH0616633A (xx)
KR (1) KR930016399A (xx)
CN (1) CN1075141A (xx)
AU (1) AU3108393A (xx)
CA (1) CA2087245A1 (xx)
CZ (1) CZ396492A3 (xx)
DE (1) DE4200714A1 (xx)
HU (1) HUT70155A (xx)
IL (1) IL104357A0 (xx)
MX (1) MX9300057A (xx)
PL (1) PL297393A1 (xx)
ZA (1) ZA93210B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4223867A1 (de) * 1992-07-20 1994-01-27 Bayer Ag Spezieller 1,4-Dihydropyridin-3,5-dicarbonsäureester, Verfahren zu seiner Herstellung und seine pharmazeutische Verwendung
CH692199A8 (fr) 1997-10-09 2002-06-14 Cermol S.A. Composes pyridiques et compositions pharmaceutique
CN102453242B (zh) * 2010-10-27 2013-05-22 中国科学院大连化学物理研究所 一种直接酯化聚合制备聚呋喃二甲酸酯的方法
CN103998038A (zh) * 2011-11-24 2014-08-20 里皮达特发展研究及咨询公司 具有hsp调节活性的1,4-二氢吡啶衍生物
CN103044316A (zh) * 2013-01-23 2013-04-17 石家庄学院 一种以咪唑离子液体为催化剂制备1,4-二氢吡啶的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883543A (en) * 1969-05-10 1975-05-13 Bayer Ag N-alkyl-1,4-dihydropyridines
DE2210667A1 (de) * 1972-03-06 1973-09-20 Bayer Ag Kondensiert aromatisch substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US3956341A (en) * 1974-02-21 1976-05-11 Smithkline Corporation 1,3,5-Tricarbo-1,4-dihydropyridines
US4975440A (en) * 1984-09-28 1990-12-04 Byk Gulden Lomberg Chemische Fabrik Gmbh Optically-active 1,4-dihydropyridine
EP0176956B1 (de) * 1984-09-28 1994-06-15 Byk Gulden Lomberg Chemische Fabrik GmbH Neue Diarylverbindungen
US4771057A (en) * 1986-02-03 1988-09-13 University Of Alberta Reduced pyridyl derivatives with cardiovascular regulating properties
US4780538A (en) * 1986-02-12 1988-10-25 Merck & Co., Inc. Process for 1,4-dihydropyridine compounds using a titanamine catalyst
DE4011695A1 (de) * 1990-04-11 1991-10-17 Bayer Ag Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
HU9300075D0 (en) 1993-04-28
HUT70155A (en) 1995-09-28
MX9300057A (es) 1993-09-01
PL297393A1 (en) 1993-10-04
AU3108393A (en) 1993-07-15
EP0551663A1 (de) 1993-07-21
ZA93210B (en) 1993-09-09
JPH0616633A (ja) 1994-01-25
DE4200714A1 (de) 1993-07-15
CZ396492A3 (en) 1993-12-15
KR930016399A (ko) 1993-08-26
CN1075141A (zh) 1993-08-11
US5342847A (en) 1994-08-30
CA2087245A1 (en) 1993-07-15

Similar Documents

Publication Publication Date Title
IL105035A0 (en) Substituted pipecolinic acid derivatives,their preparation and pharmaceutical compositions containing them
IL103932A (en) Fatty acid and pharmaceutical compositions containing them
IL107956A0 (en) Carboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
NZ250762A (en) Five-membered-heterocyclic carboxylic acid derivatives and pharmaceutical compositions
IL99725A0 (en) Saturated hydroxyalkylquinoline acids and pharmaceutical compositions containing them
IL108019A0 (en) Hydroxyiminoalkylindole-carboxylic acid derivatives their preparation and pharmaceutical compositions containing them
IL88615A0 (en) 1,7-annelated indolecarboxylic acid esters and amides,their preparation and pharmaceutical compositions containing them
IL99030A0 (en) 1,4-dihydropyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
NZ213461A (en) 1,4-dihyrdropyridine-3,5-dicarboxylic acid derivatives and pharmaceutical compositions
NZ231353A (en) Pharmaceutical compositions comprising 3,5-dihydroxy-7-(1-acyloxyhexahydronaphth-8-yl)-heptanoic acid and lactone derivatives
IL101771A0 (en) Carboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
IL104356A0 (en) Benzofuranyl-and thiophenylmethylthio-alkanecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
ZA891696B (en) Pyrimidinyl-substituted hydroxyacids,lactones and esters and pharmaceutical compositions containing them
NZ220950A (en) 1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and pharmaceutical compositions containing such compounds
IL99325A0 (en) Hetrazepinoid acid amides,their preparation and pharmaceutical compositions containing them
IL104357A0 (en) Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester,its preparation and pharmaceutical compositions containing it
IL84724A0 (en) Substituted aminomethyl-5,6,7,8-tetrahydronaphthyloxyacetic acids and esters and amides thereof,their preparation and pharmaceutical compositions containing them
IL110078A0 (en) N-substituted azaheterocyclic carboxylic acids and esters thereof, their preparation and pharmaceutical compositions containing them
IL105391A0 (en) 1,2,4-benzothiadiazine-3-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
CY1739A (en) Piperazinecarboxylic acid its preparation and pharmaceutical compositions containing it
IL108930A0 (en) 2,3-Diamino-3- hydroxycarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
IL108920A0 (en) Acyloxyhexanoic acid derivatives and pharmaceutical compositions containing them
NZ218614A (en) 16,17-butylidenedioxy-6,9-difluoro-11-hydroxy-3, 20-dioxopregna-1,4-diene-21-oic acid esters and pharmaceutical compositions
IL106369A0 (en) A specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester,its preparation and pharmaceutical compositions containing it
IL115030A0 (en) Use of 1,4-dihydropyridine - 3,5-dicarboxylic acid esters as medicaments